[1] 贾保昌,罗小玲,梁嵘,等.联合检测血清GP73和AFP对原发性肝癌诊断价值的探讨.中华肿瘤防治杂志, 2012, 19:832-835.
[2] 许文芳,费迎明,周建康,等.血清GP73、AFP和AFP-L3联合检测在原发性肝癌诊断中的价值.中华实验和临床病毒学杂志, 2011, 25:286-288.
[3] 赵春华,周文峰,陈维华,等.甲胎蛋白在原发性肝癌首诊中的价值.临床肝胆病杂志, 2013, 29:698-701.
[4] 丁艳,李丹,王念跃,等.高尔基蛋白73、甲胎蛋白异质体3、甲胎蛋白和 α-L-岩藻糖苷酶在肝脏疾病中的诊断价值.临床肝胆病杂志, 2014, 30:785-789.
[5] Yamamoto K, Imamura H, Matsuyama Y, et al. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinico pathological variables of HCC. J Gastroenterology, 2010, 45:1272-1282.
[6] 张勤,单洪丽,续薇.血清高尔基体糖蛋白73、甲胎蛋白及甲胎蛋白异质体3在肝癌诊断及射频消融术后复发监测中的应用价值.临床肝胆病杂志, 2015, 31:232-235.
[7] 张宗勤,艾莉,张小峰,等.甲胎蛋白异质体AFP-L3对肝癌切除术后复发的判断价值.第二军医大学学报, 2013, 34:407-410.
[8] 孔祥亘,韩绍磊,郑昭敏,等.高尔基体蛋白73联合甲胎蛋白异质体在原发性肝癌诊断中的价值.山东大学学报(第一版), 2011, 49:110-114.
[9] Yao S, Zhang J, Chen H, et al. Diagnostic value of immuno histochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.J Histochem Cytochem, 2013, 61:639-648.
[10] 张原琪,唐礼新,黄里.血清肿瘤标志物联合检测对原发性肝癌诊断的价值.中国医疗前沿, 2010, 5:69-70. |
